Ideas to action: independent research for global prosperity
Women's Underrepresentation in IFI Leadership
November 27, 2023
EU-Africa Strategy: State of Play
November 24, 2023
Malaria Case Management After the Affordable Medicines Facility for Malaria (AMFm): Availability, Quality, and Market Share for ACTs in Kenya’s Private Pharmacies
December 14, 2020
Between 2011 and 2016, the Affordable Medicines Facility-Malaria (AMFm) subsidy program substantially increased access to WHO prequalified artemisinin combination therapies (ACTs) through Africa’s private sector pharmacies and drug-sellers. While the program was rigorously and extensively evaluated,...
WHITE HOUSE AND THE WORLD POLICY BRIEFS
Rebuilding US Global Health Leadership for Impact and Shared Security
December 03, 2020
Testimony before the USITC on COVID-19 Related Medical Supply Chains
October 22, 2020
On Wednesday, September 23, CGD Senior Fellow Prashant Yadav appeared before the United States International Trade Commission (USITC) at a virtual hearing examining “COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges.” His testimony focused on trade and s...
COVID-19 Vaccine Predictions: Using Mathematical Modelling and Expert Opinions to Estimate Timelines and Probabilities of Success of COVID-19 Vaccines
October 01, 2020
We collected publicly available information, interviewed experts, and used our diverse range of expertise to analyse and model the COVID-19 vaccine portfolio in order to generate predictions about the vaccine portfolio's timeline.
Family Planning and The Global Financing Facility: Current Evidence and a Learning Agenda
September 28, 2020
To achieve the SDG 2030 milestone—“universal access” to voluntary, high-quality family planning (FP) services—international FP funders and advocates seek to increase and sustain FP financing in low- and middle-income countries (LMICs).
Testimony on Critical US Supply Chains Amid the COVID-19 Pandemic
July 24, 2020
On July 23, 2020, CGD Senior Fellow Prashant Yadav appeared before the House Ways and Means Subcommittee on Trade at a hearing titled “Trade, Manufacturing, and Critical Supply Chains: Lessons From COVID-19.” Yadav’s testimony noted the vulnerabilities in supply chains for medical products clearly e...
COVID-19 and Budgetary Space for Health in Developing Economies
July 16, 2020
The sizeable economic and health consequences of COVID-19 are clear as the pandemic spreads, translating into additional burden on health systems not just now but for years to come.